Diabetes mellitus and stroke: Diagnosis, nursing interdisciplinary management, and medical secretary documentation practices

Naif Lahiq Mohsen Alotaiby; Awadh Awaadh Saad Alotaiby; Tariq Abdulaziz Al-Falih; Shams Mohammed Alqahtani; Ola Yousef Fadan; Ali Khalil Hassan Khader

doi:10.53730/ijhs.v1nS1.15342

Authors

Naif Lahiq Mohsen Alotaiby KSA, National Guard Health Affairs
Awadh Awaadh Saad Alotaiby KSA, National Guard Health Affairs
Tariq Abdulaziz Al-Falih KSA, National Guard Health Affairs
Shams Mohammed Alqahtani KSA, National Guard Health Affairs
Ola Yousef Fadan KSA, National Guard Health Affairs
Ali Khalil Hassan Khader KSA, National Guard Health Affairs

Keywords:

Diabetes Mellitus, Stroke, Glycemic Control, Interdisciplinary Management, Nursing Protocols, Documentation Practices, Ischemic Stroke, Cardiovascular Diseases, Hyperglycemia

Abstract

Background: Diabetes mellitus (DM) is a well-established risk factor for cardiovascular diseases (CVD), including stroke. As the global prevalence of diabetes continues to rise, so does its contribution to the increasing incidence of stroke, particularly ischemic strokes. The coexistence of diabetes with other stroke risk factors, such as hypertension, dyslipidemia, and obesity, significantly amplifies stroke risk. Diabetes management post-stroke is complex, and inadequate control of blood glucose increases the risk of recurrent strokes and worsens patient outcomes. Aim: This article aims to explore the epidemiology, pathophysiological mechanisms, diagnostic approaches, and interdisciplinary management strategies for stroke in patients with diabetes. It focuses on the role of nursing in managing these patients, including documentation practices and the integration of protocols that address both acute and long-term diabetes management in the context of stroke care. Methods: A comprehensive review of existing literature and clinical studies was conducted to assess the relationship between diabetes and stroke. Key databases were searched for studies that focus on epidemiological trends, stroke patterns in diabetic populations, glycemic management during the acute phase of stroke, and the role of nursing in interdisciplinary stroke care.

Downloads

Download data is not yet available.

References

International Diabetes Federation. IDF Diabetes Atlas - 7th Edition ([accessed 2016 Available from:

World Health Organization. Ageing and health (WHO, Geneva. 2015, [accessed. 2016. Available from: http://www.who.int/mediacentre/factsheets/fs404/en/

Dutton GR, Lewis CE. The Look AHEAD Trial: Implications for Lifestyle Intervention in Type 2 Diabetes Mellitus. Prog Cardiovasc Dis. 2015;58:69–75. doi: 10.1016/j.pcad.2015.04.002. DOI: https://doi.org/10.1016/j.pcad.2015.04.002

Maahs DM, Daniels SR, de Ferranti SD, Dichek HL, Flynn J, Goldstein BI, Kelly AS, Nadeau KJ, Martyn-Nemeth P, Osganian SK, et al. Cardiovascular disease risk factors in youth with diabetes mellitus: a scientific statement from the American Heart Association. Circulation. 2014;130:1532–1558. doi: 10.1161/CIR.0000000000000094. DOI: https://doi.org/10.1161/CIR.0000000000000094

Krishnamurthi RV, Feigin VL, Forouzanfar MH, Mensah GA, Connor M, Bennett DA, Moran AE, Sacco RL, Anderson LM, Truelsen T, et al. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet Glob Health. 2013;1:e259–e281. doi: 10.1016/S2214-109X(13)70089-5. DOI: https://doi.org/10.1016/S2214-109X(13)70089-5

Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Després JP, Fullerton HJ, et al. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation. 2016;133:e38–360. doi: 10.1161/CIR.0000000000000350. DOI: https://doi.org/10.1161/CIR.0000000000000366

Zhu S, McClure LA, Lau H, Romero JR, White CL, Babikian V, Nguyen T, Benavente OR, Kase CS, Pikula A. Recurrent vascular events in lacunar stroke patients with metabolic syndrome and/or diabetes. Neurology. 2015;85:935–941. doi: 10.1212/WNL.0000000000001933. DOI: https://doi.org/10.1212/WNL.0000000000001933

Shou J, Zhou L, Zhu S, Zhang X. Diabetes is an Independent Risk Factor for Stroke Recurrence in Stroke Patients: A Meta-analysis. J Stroke Cerebrovasc Dis. 2015;24:1961–1968. doi: 10.1016/j.jstrokecerebrovasdis.2015.04.004. DOI: https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.04.004

Shah AD, Langenberg C, Rapsomaniki E, Denaxas S, Pujades-Rodriguez M, Gale CP, Deanfield J, Smeeth L, Timmis A, Hemingway H. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people. Lancet Diabetes Endocrinol. 2015;3:105–113. doi: 10.1016/S2213-8587(14)70219-0. DOI: https://doi.org/10.1016/S2213-8587(14)70219-0

Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979;241:2035–2038. doi: 10.1001/jama.241.19.2035. DOI: https://doi.org/10.1001/jama.241.19.2035

Abbott RD, Donahue RP, MacMahon SW, Reed DM, Yano K. Diabetes and the risk of stroke. The Honolulu Heart Program. JAMA. 1987;257:949–952. DOI: https://doi.org/10.1001/jama.257.7.949

Manson JE, Colditz GA, Stampfer MJ, Willett WC, Krolewski AS, Rosner B, Arky RA, Speizer FE, Hennekens CH. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med. 1991;151:1141–1147. DOI: https://doi.org/10.1001/archinte.151.6.1141

Kuusisto J, Mykkänen L, Pyörälä K, Laakso M. Non-insulin-dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects. Stroke. 1994;25:1157–1164. doi: 10.1161/01.str.25.6.1157. DOI: https://doi.org/10.1161/01.STR.25.6.1157

Stegmayr B, Asplund K. Diabetes as a risk factor for stroke. A population perspective. Diabetologia. 1995;38:1061–1068. doi: 10.1007/BF00402176. DOI: https://doi.org/10.1007/BF00402176

Folsom AR, Rasmussen ML, Chambless LE, Howard G, Cooper LS, Schmidt MI, Heiss G. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Diabetes Care. 1999;22:1077–1083. doi: 10.2337/diacare.22.7.1077. DOI: https://doi.org/10.2337/diacare.22.7.1077

Wannamethee SG, Perry IJ, Shaper AG. Nonfasting serum glucose and insulin concentrations and the risk of stroke. Stroke. 1999;30:1780–1786. doi: 10.1161/01.str.30.9.1780. DOI: https://doi.org/10.1161/01.STR.30.9.1780

Hart CL, Hole DJ, Smith GD. Comparison of risk factors for stroke incidence and stroke mortality in 20 years of follow-up in men and women in the Renfrew/Paisley Study in Scotland. Stroke. 2000;31:1893–1896. doi: 10.1161/01.str.31.8.1893. DOI: https://doi.org/10.1161/01.STR.31.8.1893

Abu-Lebdeh HS, Hodge DO, Nguyen TT. Predictors of macrovascular disease in patients with type 2 diabetes mellitus. Mayo Clin Proc. 2001;76:707–712. doi: 10.4065/76.7.707. DOI: https://doi.org/10.4065/76.7.707

Aronow WS, Ahn C. Risk factors for new atherothrombotic brain infarction in older Hispanic men and women. J Gerontol A Biol Sci Med Sci. 2002;57:M61–M63. doi: 10.1093/gerona/57.1.m61. DOI: https://doi.org/10.1093/gerona/57.1.M61

Woodward M, Zhang X, Barzi F, Pan W, Ueshima H, Rodgers A, MacMahon S. The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. Diabetes Care. 2003;26:360–366. doi: 10.2337/diacare.26.2.360. DOI: https://doi.org/10.2337/diacare.26.2.360

Hu FB, Stampfer MJ, Solomon CG, Liu S, Willett WC, Speizer FE, Nathan DM, Manson JE. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med. 2001;161:1717–1723. doi: 10.1001/archinte.161.14.1717. DOI: https://doi.org/10.1001/archinte.161.14.1717

Khoury JC, Kleindorfer D, Alwell K, Moomaw CJ, Woo D, Adeoye O, Flaherty ML, Khatri P, Ferioli S, Broderick JP, et al. Diabetes mellitus: a risk factor for ischemic stroke in a large biracial population. Stroke. 2013;44:1500–1504. doi: 10.1161/STROKEAHA.113.001318. DOI: https://doi.org/10.1161/STROKEAHA.113.001318

Karapanayiotides T, Piechowski-Jozwiak B, van Melle G, Bogousslavsky J, Devuyst G. Stroke patterns, etiology, and prognosis in patients with diabetes mellitus. Neurology. 2004;62:1558–1562. doi: 10.1212/01.wnl.0000123252.55688.05. DOI: https://doi.org/10.1212/01.WNL.0000123252.55688.05

Vaidya V, Gangan N, Sheehan J. Impact of cardiovascular complications among patients with Type 2 diabetes mellitus: a systematic review. Expert Rev Pharmacoecon Outcomes Res. 2015;15:487–497. doi: 10.1586/14737167.2015.1024661. DOI: https://doi.org/10.1586/14737167.2015.1024661

Hata J, Arima H, Rothwell PM, Woodward M, Zoungas S, Anderson C, Patel A, Neal B, Glasziou P, Hamet P, et al. Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial. Circulation. 2013;128:1325–1334. doi: 10.1161/CIRCULATIONAHA.113.002717. DOI: https://doi.org/10.1161/CIRCULATIONAHA.113.002717

Tuttolomondo A, Pinto A, Salemi G, Di Raimondo D, Di Sciacca R, Fernandez P, Ragonese P, Savettieri G, Licata G. Diabetic and non-diabetic subjects with ischemic stroke: differences, subtype distribution and outcome. Nutr Metab Cardiovasc Dis. 2008;18:152–157. doi: 10.1016/j.numecd.2007.02.003. DOI: https://doi.org/10.1016/j.numecd.2007.02.003

Jørgensen H, Nakayama H, Raaschou HO, Olsen TS. Stroke in patients with diabetes. The Copenhagen Stroke Study. Stroke. 1994;25:1977–1984. doi: 10.1161/01.str.25.10.1977. DOI: https://doi.org/10.1161/01.STR.25.10.1977

Olsson T, Viitanen M, Asplund K, Eriksson S, Hägg E. Prognosis after stroke in diabetic patients. A controlled prospective study. Diabetologia. 1990;33:244–249. doi: 10.1007/BF00404803. DOI: https://doi.org/10.1007/BF00404803

Kiers L, Davis SM, Larkins R, Hopper J, Tress B, Rossiter SC, Carlin J, Ratnaike S. Stroke topography and outcome in relation to hyperglycaemia and diabetes. J Neurol Neurosurg Psychiatry. 1992;55:263–270. doi: 10.1136/jnnp.55.4.263. DOI: https://doi.org/10.1136/jnnp.55.4.263

Weir CJ, Murray GD, Dyker AG, Lees KR. Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ. 1997;314:1303–1306. doi: 10.1136/bmj.314.7090.1303. DOI: https://doi.org/10.1136/bmj.314.7090.1303

Megherbi SE, Milan C, Minier D, Couvreur G, Osseby GV, Tilling K, Di Carlo A, Inzitari D, Wolfe CD, Moreau T, et al. Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke: data from the European BIOMED Stroke Project. Stroke. 2003;34:688–694. doi: 10.1161/01.STR.0000057975.15221.40. DOI: https://doi.org/10.1161/01.STR.0000057975.15221.40

Arboix A, Rivas A, García-Eroles L, de Marcos L, Massons J, Oliveres M. Cerebral infarction in diabetes: clinical pattern, stroke subtypes, and predictors of in-hospital mortality. BMC Neurol. 2005;5:9. doi: 10.1186/1471-2377-5-9. DOI: https://doi.org/10.1186/1471-2377-5-9

Hankey GJ, Anderson NE, Ting RD, Veillard AS, Romo M, Wosik M, Sullivan DR, O’Connell RL, Hunt D, Keech AC. Rates and predictors of risk of stroke and its subtypes in diabetes: a prospective observational study. J Neurol Neurosurg Psychiatry. 2013;84:281–287. doi: 10.1136/jnnp-2012-303365. DOI: https://doi.org/10.1136/jnnp-2012-303365

Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001;32:2426–2432. doi: 10.1161/hs1001.096194. DOI: https://doi.org/10.1161/hs1001.096194

Bangen KJ, Gu Y, Gross AL, Schneider BC, Skinner JC, Benitez A, Sachs BC, Shih R, Sisco S, Schupf N, et al. Relationship Between Type 2 Diabetes Mellitus and Cognitive Change in a Multiethnic Elderly Cohort. J Am Geriatr Soc. 2015;63:1075–1083. doi: 10.1111/jgs.13441. DOI: https://doi.org/10.1111/jgs.13441

Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54:1615–1625. doi: 10.2337/diabetes.54.6.1615. DOI: https://doi.org/10.2337/diabetes.54.6.1615

Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, Rand L, Siebert C. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986. doi: 10.1056/NEJM199309303291401. DOI: https://doi.org/10.1056/NEJM199309303291401

Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643–2653. doi: 10.1056/NEJMoa052187. DOI: https://doi.org/10.1056/NEJMoa052187

Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010;107:1058–1070. doi: 10.1161/CIRCRESAHA.110.223545. DOI: https://doi.org/10.1161/CIRCRESAHA.110.223545

El-Osta A, Brasacchio D, Yao D, Pocai A, Jones PL, Roeder RG, Cooper ME, Brownlee M. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med. 2008;205:2409–2417. doi: 10.1084/jem.20081188. DOI: https://doi.org/10.1084/jem.20081188

Ceriello A, Ihnat MA, Thorpe JE. Clinical review 2: The “metabolic memory”: is more than just tight glucose control necessary to prevent diabetic complications? J Clin Endocrinol Metab. 2009;94:410–415. doi: 10.1210/jc.2008-1824. DOI: https://doi.org/10.1210/jc.2008-1824

Li AC, Brown KK, Silvestre MJ, Willson TM, Palinski W, Glass CK. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J Clin Invest. 2000;106:523–531. doi: 10.1172/JCI10370. DOI: https://doi.org/10.1172/JCI10370

Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med. 1994;331:1188–1193. doi: 10.1056/NEJM199411033311803. DOI: https://doi.org/10.1056/NEJM199411033311803

Saremi A, Schwenke DC, Buchanan TA, Hodis HN, Mack WJ, Banerji M, Bray GA, Clement SC, Henry RR, Kitabchi AE, et al. Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factors. Arterioscler Thromb Vasc Biol. 2013;33:393–399. doi: 10.1161/ATVBAHA.112.300346. DOI: https://doi.org/10.1161/ATVBAHA.112.300346

MacDonald MR, Petrie MC, Home PD, Komajda M, Jones NP, Beck-Nielsen H, Gomis R, Hanefeld M, Pocock SJ, Curtis PS, et al. Incidence and prevalence of unrecognized myocardial infarction in people with diabetes: a substudy of the Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemia in Diabetes (RECORD) study. Diabetes Care. 2011;34:1394–1396. doi: 10.2337/dc10-2398. DOI: https://doi.org/10.2337/dc10-2398

Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, Skene AM, Tan MH, Lefèbvre PJ, Murray GD, et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet. 2005;366:1279–1289. doi: 10.1016/S0140-6736(05)67528-9. DOI: https://doi.org/10.1016/S0140-6736(05)67528-9

Kernan WN, Viscoli CM, Furie KL, Young LH, Inzucchi SE, Gorman M, Guarino PD, Lovejoy AM, Peduzzi PN, Conwit R, et al. Pioglitazone after Ischemic Stroke or Transient Ischemic Attack. N Engl J Med. 2016;374:1321–1331. doi: 10.1056/NEJMoa1506930 DOI: https://doi.org/10.1056/NEJMoa1506930

Scott JF, Robinson GM, French JM, O’Connell JE, Alberti KG, Gray CS. Prevalence of admission hyperglycaemia across clinical subtypes of acute stroke. Lancet. 1999;353:376–377. doi: 10.1016/s0140-6736(05)74948-5 DOI: https://doi.org/10.1016/S0140-6736(05)74948-5

Poppe AY, Majumdar SR, Jeerakathil T, Ghali W, Buchan AM, Hill MD. Admission hyperglycemia predicts a worse outcome in stroke patients treated with intravenous thrombolysis. Diabetes Care. 2009;32:617–622. doi: 10.2337/dc08-1754 DOI: https://doi.org/10.2337/dc08-1754

Gray CS, Hildreth AJ, Sandercock PA, O’Connell JE, Johnston DE, Cartlidge NE, Bamford JM, James OF, Alberti KG. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK) Lancet Neurol. 2007;6:397–406. doi: 10.1016/S1474-4422(07)70080-7 DOI: https://doi.org/10.1016/S1474-4422(07)70080-7

Ntaios G, Papavasileiou V, Bargiota A, Makaritsis K, Michel P. Intravenous insulin treatment in acute stroke: a systematic review and meta-analysis of randomized controlled trials. Int J Stroke. 2014;9:489–493. doi: 10.1111/ijs.12225. DOI: https://doi.org/10.1111/ijs.12225

Jauch EC, Saver JL, Adams HP, Bruno A, Connors JJ, Demaerschalk BM, Khatri P, McMullan PW, Qureshi AI, Rosenfield K, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870–947. doi: 10.1161/STR.0b013e318284056a. DOI: https://doi.org/10.1161/STR.0b013e318284056a

Malmberg K, Rydén L, Wedel H, Birkeland K, Bootsma A, Dickstein K, Efendic S, Fisher M, Hamsten A, Herlitz J, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005;26:650–661. doi: 10.1093/eurheartj/ehi199. DOI: https://doi.org/10.1093/eurheartj/ehi199

Raz I, Wilson PW, Strojek K, Kowalska I, Bozikov V, Gitt AK, Jermendy G, Campaigne BN, Kerr L, Milicevic Z, et al. Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial. Diabetes Care. 2009;32:381–386. doi: 10.2337/dc08-1671. DOI: https://doi.org/10.2337/dc08-1671

Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577–1589. doi: 10.1056/NEJMoa0806470. DOI: https://doi.org/10.1056/NEJMoa0806470

Gerstein HC, Miller ME, Byington RP, Goff DC, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545–2559. doi: 10.1056/NEJMoa0802743. DOI: https://doi.org/10.1056/NEJMoa0802743

Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560–2572. doi: 10.1056/NEJMoa0802987. DOI: https://doi.org/10.1056/NEJMoa0802987

Orchard TJ, Nathan DM, Zinman B, Cleary P, Brillon D, Backlund JY, Lachin JM. Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality. JAMA. 2015;313:45–53. doi: 10.1001/jama.2014.16107. DOI: https://doi.org/10.1001/jama.2014.16107

Fox CS, Golden SH, Anderson C, Bray GA, Burke LE, de Boer IH, Deedwania P, Eckel RH, Ershow AG, Fradkin J, et al. Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. Circulation. 2015;132:691–718. doi: 10.1161/CIR.0000000000000230 DOI: https://doi.org/10.1161/CIR.0000000000000230

de Ferranti SD, de Boer IH, Fonseca V, Fox CS, Golden SH, Lavie CJ, Magge SN, Marx N, McGuire DK, Orchard TJ, et al. Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association. Circulation. 2014;130:1110–1130. doi: 10.1161/CIR.0000000000000034. DOI: https://doi.org/10.1161/CIR.0000000000000034

Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360:129–139. doi: 10.1056/NEJMoa0808431. DOI: https://doi.org/10.1056/NEJMoa0808431

Turnbull FM, Abraira C, Anderson RJ, Byington RP, Chalmers JP, Duckworth WC, Evans GW, Gerstein HC, Holman RR, Moritz TE, et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia. 2009;52:2288–2298. doi: 10.1007/s00125-009-1470-0. DOI: https://doi.org/10.1007/s00125-009-1470-0

Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383–393. doi: 10.1056/NEJMoa021778. DOI: https://doi.org/10.1056/NEJMoa021778